Bio-Rad Laboratories Inc. - Ordinary Shares - Class B
BIO.B
Market Cap$9.24B
Close$
Share Statistics
| Market cap | $9.24 Billion |
|---|---|
| Enterprise Value | $8.83 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-21.82 |
| Beta | 0.0 |
| Outstanding Shares | 5,095,930 |
| Avg 30 Day Volume | 214 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -14.5 |
|---|---|
| PEG | 24.98 |
| Price to Sales | 0.53 |
| Price to Book Ratio | 0.16 |
| Enterprise Value to Revenue | 3.31 |
| Enterprise Value to EBIT | 26.15 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
ESG Score
No data
About Bio-Rad Laboratories Inc.
CEO: Norman Schwartz